Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Tangen

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
JCO Oncology Practice|June 7, 2023
Crisis of the Clinical Trials Staff Attrition After the COVID-19 PandemicGrace Sun, Don S Dizon, Connie M Szczepanek, et al.
The Journal of Urology|December 29, 2025
Whole-Slide Telepathology Grading of Prostate Cancer in Biopsies Using ISUP Criteria: Inter- and Intra-Observer Concordance and Implications for Active SurveillanceM Scott Lucia, Sam Callis, Catherine Tangen, et al.
Journal of the National Cancer Institute|February 26, 2014
Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421Primo N Lara, Benjamin Ely, David I Quinn, et al.
Prostate Cancer and Prostatic Diseases|February 29, 2024
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronelPrimo N Lara, Edward Mayerson, Erik Gertz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
European Urology|April 21, 2023
Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without OrteronelPrimo N Lara, Edward Mayerson, Erik Gertz, et al.
JAMA Network Open|August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical TrialShuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
European Urology Oncology|November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216Umang Swami, Yeonjung Jo, Arshit Narang, et al.
The Journal of Urology|January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomesMichael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate CancerSusan Halabi, Akash Roy, Larysa Rydzewska, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
JCO Oncology Practice|June 7, 2023
Crisis of the Clinical Trials Staff Attrition After the COVID-19 PandemicGrace Sun, Don S Dizon, Connie M Szczepanek, et al.
The Journal of Urology|December 29, 2025
Whole-Slide Telepathology Grading of Prostate Cancer in Biopsies Using ISUP Criteria: Inter- and Intra-Observer Concordance and Implications for Active SurveillanceM Scott Lucia, Sam Callis, Catherine Tangen, et al.
Journal of the National Cancer Institute|February 26, 2014
Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421Primo N Lara, Benjamin Ely, David I Quinn, et al.
Prostate Cancer and Prostatic Diseases|February 29, 2024
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronelPrimo N Lara, Edward Mayerson, Erik Gertz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
European Urology|April 21, 2023
Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without OrteronelPrimo N Lara, Edward Mayerson, Erik Gertz, et al.
JAMA Network Open|August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical TrialShuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
European Urology Oncology|November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216Umang Swami, Yeonjung Jo, Arshit Narang, et al.
The Journal of Urology|January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomesMichael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate CancerSusan Halabi, Akash Roy, Larysa Rydzewska, et al.
Pageof 4